SeaStar Medical Holding Corporation
ICU
$4.14
$0.276.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 814.07% | 1,195.59% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 814.07% | 1,195.59% | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 774.81% | 1,135.29% | -- | -- | -- |
| SG&A Expenses | -34.22% | -23.23% | -16.74% | 5.92% | 5.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -25.42% | -9.06% | 5.91% | 31.67% | 24.76% |
| Operating Income | 31.77% | 14.11% | -0.70% | -28.56% | -23.82% |
| Income Before Tax | 51.07% | 54.26% | 55.04% | 50.05% | 5.36% |
| Income Tax Expenses | 0.00% | 250.00% | 250.00% | -- | -- |
| Earnings from Continuing Operations | 51.07% | 54.25% | 55.03% | 50.04% | 5.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 51.07% | 54.25% | 55.03% | 50.04% | 5.34% |
| EBIT | 31.77% | 14.11% | -0.70% | -28.56% | -23.82% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 89.34% | 87.33% | 87.52% | 85.58% | 76.42% |
| Normalized Basic EPS | 89.34% | 87.46% | 82.45% | 80.72% | 71.10% |
| EPS Diluted | 89.34% | 87.33% | 87.52% | 85.58% | 76.42% |
| Normalized Diluted EPS | 89.34% | 87.46% | 82.45% | 80.72% | 71.10% |
| Average Basic Shares Outstanding | 456.10% | 346.91% | 253.76% | 269.29% | 328.58% |
| Average Diluted Shares Outstanding | 456.10% | 346.91% | 253.76% | 269.29% | 328.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |